Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease

Journal of cardiology
Tomoya YamashitaKen-Ichi Hirata

Abstract

Atherosclerosis is believed to be a chronic inflammation of the arterial wall and various immune cells of innate and adaptive immunity involves in the pathogenesis of atherosclerosis. Based on this notion, several anti-inflammatory strategies for prevention of atherosclerosis have been examined mainly using animal models. Vaccination or mucosal immunization with athero-antigens comes under candidate therapeutic methods for antigen-specific prevention of atherosclerosis. Immune suppression mediated by regulatory T cells (Tregs) could be another method to regulate pathogenic chronic inflammation in atherogenesis. Inducible Tregs are reported to differentiate peripherally in the intestine and we have been interested in the oral tolerance, in which not only Tregs but also tolerogenic dendritic cells play crucial roles. We demonstrated that modulation of the intestinal immunity including oral tolerance could be a novel therapy against atherosclerosis. Further, downregulation of effector T cell response and/or Treg predominant condition was shown to induce atherosclerosis regression and inhibit the progression of aneurysm. In clinical situations, none of the approaches to specifically and directly treat inflammation to prevent cardio...Continue Reading

References

Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·W PalinskiJ L Witztum
Jun 22, 1999·The New England Journal of Medicine·G D Sloop
May 31, 2002·The New England Journal of Medicine·Kevan C HeroldJeffrey A Bluestone
Oct 4, 2002·The New England Journal of Medicine·Joep Killestein
Apr 22, 2005·The New England Journal of Medicine·Göran K Hansson
Feb 8, 2006·Nature Medicine·Hafid Ait-OufellaZiad Mallat
Jun 8, 2007·American Journal of Physiology. Cell Physiology·Tomoya YamashitaMitsuhiro Yokoyama
Jul 21, 2007·Nature Reviews. Immunology·Lucienne Chatenoud, Jeffrey A Bluestone
Jan 9, 2008·Circulation·Thomas J WangRamachandran S Vasan
May 31, 2008·Cell·Shimon SakaguchiMasahiro Ono
Jun 14, 2008·Clinical & Developmental Immunology·Natalia MiliotiErnesto Oviedo-Orta
Oct 7, 2008·Trends in Immunology·Noriko M Tsuji, Akemi Kosaka
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Apr 15, 2011·Immunological Reviews·Howard L WeinerHenry Wu
Nov 9, 2011·Nature Medicine·Christian Weber, Heidi Noels
Apr 14, 2012·Journal of Atherosclerosis and Thrombosis·Naoto SasakiKen-ichi Hirata
Jul 21, 2012·Current Opinion in Lipidology·Jan NilssonGunilla Nordin Fredrikson
Feb 22, 2013·The Journal of Clinical Investigation·Roland KlingenbergGöran K Hansson
Apr 24, 2014·Journal of the American Heart Association·Kazuyuki KasaharaKen-Ichi Hirata
May 24, 2014·Circulation Research·Dimitrios TsiantoulasChristoph J Binder
Jun 7, 2014·Circulation Research·Jacob Fog BentzonErling Falk
Dec 30, 2014·Journal of the American College of Cardiology·Prediman K ShahJan Nilsson

❮ Previous
Next ❯

Citations

Oct 21, 2015·Seminars in Immunopathology·Tomohiro NumataRyuji Inoue
May 4, 2016·Journal of cardiology·Mikiko HaradaUNKNOWN Study Project on Prevention of Metabolic Syndrome among Children, Adolescents, and Young Adults in Shinshu
Jul 16, 2016·International Journal of Cardiology·Alberto J Lorenzatti, Brenda M Retzlaff
Jun 23, 2018·European Journal of Immunology·Kouji KobiyamaKlaus Ley
Jan 30, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Klaus Ley
Jul 16, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Olivier HerbinKonstantina Alexandropoulos
May 11, 2019·American Journal of Physiology. Heart and Circulatory Physiology·Robert M BlantonPilar Alcaide
Nov 9, 2019·Journal of Clinical Pharmacy and Therapeutics·Li ChenDazhuo Shi
Mar 7, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A H KatsanosG Tsivgoulis
Jul 28, 2020·JAMA Neurology·Aristeidis H Katsanos, Robert G Hart
Oct 3, 2018·The Journal of Clinical Investigation·Sarah A RobertsonLachlan M Moldenhauer
Apr 16, 2019·Frontiers in Immunology·Sarah A RobertsonGustaaf Dekker
Aug 21, 2019·Frontiers in Immunology·Tianyu CaoGang Wang
Nov 15, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Tessa J Barrett
Feb 26, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Sandi L NavarroEmily White
May 25, 2021·Frontiers in Molecular Biosciences·Ping LinShou-Dong Guo
Sep 5, 2021·BMC Medical Genomics·Timothy A McCaffreyGeorges St Laurent

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Journal of Atherosclerosis and Thrombosis
Naoto SasakiKen-Ichi Hirata
Seminars in Immunopathology
Hafid Ait-OufellaAlain Tedgui
© 2022 Meta ULC. All rights reserved